BNC KOREA. Inc. 256840

KRX · South Korea · Retail Trade

KRW 3,275.00+15.00 (+0.46%)

Market closed· Oct 1, 2026, 6:30 AM UTC· KRW · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

BNC KOREA. Inc. 256840

KRX · South Korea · Retail Trade

KRW 3,275.00+15.00 (+0.46%)

Market closed· Oct 1, 2026, 6:30 AM UTC· KRW · Data may be delayed

Company news

Yahoo FinanceJan 26, 2026

Leios Therapeutics and BNC Korea Announce Strategic Collaboration to Accelerate Development of 10XB-101 in South Korea

10XB-101 Being Developed for Focal Fat Reduction and Body ContouringLA JOLLA, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Leios Therapeutics, a clinical-stage biotechnology company focused on innovative aesthetic therapies, today announced the execution of a licensing agreement for 10XB-101, its investigational product for focal fat reduction and body contouring, along with a strategic equity investment by BNC Korea (KOSDAQ:256840), a leading healthcare and aesthetics-focused company in South Kore

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.

Prices may be delayed and are for informational purposes only - not investment advice.